Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Precedings
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • RSS feed
  1. nature
  2. nature precedings
  3. articles
  4. article
Discovery of multiple lead compounds as M2 inhibitors through the focused screening of a small primary amine library.
Download PDF
Download PDF
  • Manuscript
  • Open access
  • Published: 26 August 2009

Discovery of multiple lead compounds as M2 inhibitors through the focused screening of a small primary amine library.

  • Wenhui Hu1,
  • Shaogao Zeng1,
  • Chufang Li1,
  • Yanling Jie1,
  • Zhiyuan Li1 &
  • …
  • Ling Chen1 

Nature Precedings (2009)Cite this article

  • 515 Accesses

  • Metrics details

Abstract

The discovery of new anti-influenza drugs is urgent, particularly considering the recent threat of swine flu. In this study, the influenza virus M2 protein was expressed in HEK293 cells and shown to have selective ion channel activity for monovalent ions. The anti-influenza virus drug amantadine hydrochloride significantly attenuated the inward current induced by hyperpolarization of HEK293 cell membranes. Although adamantine derivatives are the only M2 drugs for influenza virus A, their use is limited in the US due to drug resistance. Here we report the discovery of multiple M2 inhibitor lead compounds that were rapidly generated through focused screening of a small primary amine library. The screen was designed using a scaffold-hopping strategy based on amantadine. This study suggests that an antiviral compound directed against a conserved motif may be more useful than amantadine in inhibiting viral replication.

Similar content being viewed by others

Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (Mpro)

Article Open access 06 May 2024

Multiplexed multicolor antiviral assay amenable for high-throughput research

Article Open access 02 January 2024

Computational investigation in inhibitory effects of amantadine on classical swine fever virus p7 ion channel activity

Article Open access 02 September 2024

Article PDF

Author information

Authors and Affiliations

  1. Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences https://www.nature.com/nature

    Wenhui Hu, Shaogao Zeng, Chufang Li, Yanling Jie, Zhiyuan Li & Ling Chen

Authors
  1. Wenhui Hu
    View author publications

    Search author on:PubMed Google Scholar

  2. Shaogao Zeng
    View author publications

    Search author on:PubMed Google Scholar

  3. Chufang Li
    View author publications

    Search author on:PubMed Google Scholar

  4. Yanling Jie
    View author publications

    Search author on:PubMed Google Scholar

  5. Zhiyuan Li
    View author publications

    Search author on:PubMed Google Scholar

  6. Ling Chen
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Creative Commons Attribution 3.0 License.

Reprints and permissions

About this article

Cite this article

Hu, W., Zeng, S., Li, C. et al. Discovery of multiple lead compounds as M2 inhibitors through the focused screening of a small primary amine library.. Nat Prec (2009). https://doi.org/10.1038/npre.2009.3688.1

Download citation

  • Received: 26 August 2009

  • Accepted: 26 August 2009

  • Published: 26 August 2009

  • DOI: https://doi.org/10.1038/npre.2009.3688.1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Anti-influenza drugs; M2 inhibitors; Focused screening; Lead compound
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Precedings (Nat Preced)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing